THE MOST COMMON INFECTIOUS DISEASES IN THE NEONATAL PERIOD: CLINICAL FEATURES, DIAGNOSIS, AND PREVENTION

https://ijmri.de/index.php/jmsi

volume 4, issue 4, 2025

1283

THE MOST COMMON INFECTIOUS DISEASES IN THE NEONATAL PERIOD:

CLINICAL FEATURES, DIAGNOSIS, AND PREVENTION

Nishonova Dilafruz Valijonovna

Andijan State Medical Institute

Abstract:

Neonatal infections are among the leading causes of mortality in the first 28 days of

life, especially in developing countries. The immaturity of the neonatal immune system and

exposure to environmental and maternal pathogens increase susceptibility to infection. This

article provides a structured overview of the most common infectious diseases encountered in the

neonatal period, including sepsis, pneumonia, meningitis, conjunctivitis, umbilical infections,

and congenital (TORCH) infections. We review the epidemiology, clinical presentation,

diagnostic approaches, treatment strategies, and preventive measures. Emphasis is placed on

evidence-based methods to reduce infection-related morbidity and mortality in neonates.

Keywords:

Neonatal infection, sepsis, meningitis, pneumonia, TORCH, newborn care, neonatal

mortality

Introduction

The neonatal period, defined as the first 28 days of life, is universally recognized as a critical

phase in human development, during which infants undergo rapid physiological transitions while

simultaneously adapting to extrauterine life. Despite medical advances, this early stage remains

fraught with significant vulnerability, particularly to infectious diseases. Globally, infections

during the neonatal period account for a substantial proportion of neonatal morbidity and

mortality, especially in low- and middle-income countries. According to estimates by the World

Health Organization (WHO), neonatal infections contribute to nearly one-third of the 2.4 million

neonatal deaths that occur annually worldwide.

The heightened susceptibility of neonates to infectious agents can be attributed to several

biological and environmental factors. Immunologically, neonates have an underdeveloped innate

and adaptive immune system characterized by reduced neutrophil function, diminished

complement activity, and lower levels of immunoglobulins, especially in preterm infants.

Additionally, physical barriers such as the skin and mucosa are thinner and more permeable,

making neonates more prone to pathogen invasion. Vertical transmission from the mother—

either transplacentally, during passage through the birth canal, or through contact with maternal

fluids—further increases the risk of early infection. In contrast, late-onset infections often stem

from nosocomial sources or community-acquired pathogens, particularly in neonatal intensive

care units (NICUs) where invasive procedures and prolonged hospitalization are common.

Neonatal infections are not only associated with high fatality rates but also with significant long-

term sequelae among survivors, including neurodevelopmental impairments, hearing loss, and

chronic lung disease. The clinical presentation of infections in neonates is often subtle and non-

specific, manifesting as hypothermia, poor feeding, irritability, or respiratory distress—

symptoms that can easily be misinterpreted or overlooked. Moreover, the diagnostic process is

https://ijmri.de/index.php/jmsi

volume 4, issue 4, 2025

1284

complicated by the limited specificity of laboratory tests in neonates and the urgent need for

empirical antibiotic therapy before microbiological confirmation.

A wide spectrum of infectious diseases can affect neonates. Among the most prevalent are:

Neonatal sepsis, a systemic infection with rapid progression;

Neonatal pneumonia, which often coexists with sepsis or results from aspiration during delivery;

Meningitis, frequently associated with bacteremia and capable of causing irreversible

neurological damage;

Conjunctivitis, particularly in infants exposed to Neisseria gonorrhoeae or Chlamydia

trachomatis;

Umbilical infections (omphalitis), common in settings with poor hygienic practices;

Congenital infections, notably the TORCH complex (Toxoplasma gondii, Other, Rubella,

Cytomegalovirus, and Herpes simplex virus), which are transmitted transplacentally and can

cause multisystem damage.

Despite the availability of effective interventions—including maternal screening for Group B

Streptococcus (GBS), perinatal antiviral treatments, neonatal immunoprophylaxis, and improved

delivery room hygiene—neonatal infections continue to pose a major public health challenge.

Disparities in healthcare infrastructure, lack of trained personnel, and limited access to diagnostic

technologies further hinder the timely identification and management of infections in vulnerable

populations.

The purpose of this article is to provide a comprehensive overview of the most common

infectious diseases encountered during the neonatal period. We aim to examine their etiologies,

epidemiological trends, clinical manifestations, diagnostic approaches, and management

strategies. By synthesizing current knowledge and highlighting best practices in both high- and

low-resource settings, this review seeks to inform clinical decision-making and support efforts to

reduce neonatal mortality worldwide.

Methods

This narrative review was conducted to comprehensively examine the most common infectious

diseases occurring during the neonatal period. The methodology employed aimed to ensure a

rigorous, systematic, and clinically relevant synthesis of current evidence and best practices in

the diagnosis, treatment, and prevention of neonatal infections.

To achieve this, a structured literature search was performed using internationally recognized

medical databases, including PubMed, Scopus, and the WHO Global Health Library.

Publications ranging from January 2000 to April 2024 were screened to ensure inclusion of both

foundational and up-to-date findings. The search terms employed were derived from both

Medical Subject Headings (MeSH) and keyword combinations, including but not limited to:

“neonatal infections,” “neonatal sepsis,” “neonatal pneumonia,” “congenital TORCH infections,”

“newborn meningitis,” “neonatal conjunctivitis,” “umbilical cord infection,” and “neonatal

disease prevention.”

https://ijmri.de/index.php/jmsi

volume 4, issue 4, 2025

1285

Inclusion criteria for selected literature were as follows: studies or guidelines must pertain

specifically to neonates (defined as infants aged 0 to 28 days); address one or more of the

following domains—clinical presentation, causative pathogens, diagnostic procedures,

therapeutic strategies, or preventive interventions; and be published in peer-reviewed English-

language journals or by reputable health organizations. Both original research and high-quality

reviews were considered, including randomized controlled trials, cohort studies, systematic

reviews, and meta-analyses.

Exclusion criteria comprised non-English publications, studies exclusively concerning older

infants or children, case reports with insufficient generalizability, and preclinical studies not

directly applicable to neonatal healthcare. Additionally, opinion pieces or editorials lacking

empirical data were not included.

The process of data extraction involved a qualitative thematic analysis. Each article was assessed

in detail, and relevant data were organized into thematic categories such as type of infection,

mode of transmission, predominant pathogens, clinical features, diagnostic modalities, treatment

regimens, and evidence-based preventive strategies. This categorization allowed for the

identification of trends and gaps in clinical knowledge, as well as a comparison of global

practices in neonatal infection management.

Where possible, findings were stratified by infection type—such as early-onset versus late-onset

neonatal sepsis, or congenital versus perinatally acquired infections—to delineate clinical

distinctions and pathophysiological mechanisms. Special attention was paid to the

epidemiological differences observed between low-resource and high-income settings, in

recognition of the varying accessibility to diagnostic and therapeutic resources.

As this study involved secondary data analysis of publicly available research and did not engage

human participants or confidential data, formal ethical approval was not required. However, all

included studies were critically evaluated for methodological rigor and ethical standards in line

with internationally accepted principles.

Through this methodological framework, the review sought not only to provide a current and

clinically applicable understanding of neonatal infectious diseases but also to highlight

opportunities for prevention and areas requiring further research.

Results

A thorough analysis of the selected literature revealed that neonatal infectious diseases remain a

significant global health burden, particularly in low- and middle-income countries. The most

prevalent and clinically impactful infections in neonates include sepsis, pneumonia, meningitis,

congenital (TORCH) infections, conjunctivitis, omphalitis, and neonatal tetanus. Each of these

diseases presents with distinct etiological profiles, modes of transmission, clinical manifestations,

and outcomes.

Neonatal Sepsis

Neonatal sepsis emerged as the most frequently reported and life-threatening infection during the

neonatal period. It was observed in both early-onset (≤72 hours of life) and late-onset (>72 hours)

forms. Early-onset sepsis (EOS) was predominantly associated with vertical transmission of

pathogens from the maternal genital tract. The most commonly isolated organisms included

Group B Streptococcus (GBS), accounting for approximately 30–40% of EOS cases, and

https://ijmri.de/index.php/jmsi

volume 4, issue 4, 2025

1286

Escherichia coli, particularly in preterm infants.

Late-onset sepsis (LOS), in contrast, was more commonly linked to nosocomial or community-

acquired sources, especially in neonates requiring prolonged hospitalization or invasive

procedures. Pathogens such as Staphylococcus aureus, Klebsiella pneumoniae, Pseudomonas

aeruginosa, and Candida species were frequently implicated. Blood cultures remained the gold

standard for diagnosis, although their sensitivity was limited by low-volume sampling and prior

antibiotic exposure. Clinical signs—including temperature instability, respiratory distress,

lethargy, and feeding intolerance—were often non-specific and required high clinical suspicion.

Despite the availability of empirical treatment protocols, including combinations such as

ampicillin with gentamicin for EOS and third-generation cephalosporins for LOS, mortality rates

remained high, ranging between 15% and 30% in some resource-limited settings. Moreover,

survivors of severe sepsis exhibited increased risks for long-term complications such as

neurodevelopmental delay and cerebral palsy.

Neonatal Pneumonia

Neonatal pneumonia was identified as the second most common cause of infectious mortality in

the first month of life. It often coexisted with sepsis, particularly in early-onset cases. Studies

indicated that aspiration of infected amniotic fluid or colonized vaginal flora during delivery

played a key role in transmission. Common pathogens included GBS, E. coli, and Chlamydia

trachomatis, with viral agents such as respiratory syncytial virus (RSV) emerging as important

contributors in late-onset community-acquired pneumonia.

Clinically, pneumonia manifested with tachypnea, grunting, chest retractions, cyanosis, and

hypoxemia. Radiographic findings varied but typically showed bilateral infiltrates, perihilar

haziness, or lobar consolidation. Diagnosis was often presumptive, based on clinical and

radiological findings, in conjunction with elevated inflammatory markers.

The use of supplemental oxygen, mechanical ventilation, and broad-spectrum antibiotics formed

the cornerstone of treatment. Mortality remained significant, particularly in neonates with

underlying prematurity or birth asphyxia. Reports also emphasized the growing concern of

antimicrobial resistance, especially in NICU-acquired pneumonia, necessitating the use of

second-line agents such as meropenem or vancomycin.

Neonatal Meningitis

Bacterial meningitis was frequently reported as a complication of sepsis, particularly in preterm

infants and those with prolonged rupture of membranes. The predominant causative agents

mirrored those seen in sepsis: GBS, E. coli (especially K1 strain), and Listeria monocytogenes.

The incidence of neonatal meningitis was estimated at 0.2 to 0.4 per 1,000 live births in high-

income countries, but significantly higher in low-resource settings.

Neonates with meningitis often presented with subtle neurologic symptoms including irritability,

poor feeding, hypotonia, seizures, and bulging fontanelle. Cerebrospinal fluid (CSF) analysis

following lumbar puncture typically revealed elevated protein, reduced glucose, and pleocytosis.

However, in a notable percentage of cases, culture-negative meningitis was reported due to prior

antibiotic administration.

Mortality rates for neonatal meningitis ranged from 10% to 20% in term infants and up to 40% in

preterm neonates. Among survivors, a high proportion developed long-term sequelae including

https://ijmri.de/index.php/jmsi

volume 4, issue 4, 2025

1287

hydrocephalus, sensorineural hearing loss, and cognitive impairments. Extended antibiotic

therapy, lasting 14 to 21 days depending on the organism, was the mainstay of treatment, often

administered alongside supportive care in intensive care settings.

Congenital Infections (TORCH Complex)

The TORCH group of congenital infections—comprising Toxoplasma gondii, Other (syphilis,

varicella-zoster, HIV), Rubella, Cytomegalovirus (CMV), and Herpes simplex virus (HSV)—

represented a significant category of vertically transmitted infections.

Cytomegalovirus was the most common congenital infection worldwide, with an estimated

prevalence of 0.5–2% of all live births. Clinical manifestations ranged from asymptomatic to

severe, with symptomatic cases showing microcephaly, hepatosplenomegaly, petechiae,

sensorineural hearing loss, and intracranial calcifications.

Toxoplasmosis was particularly associated with maternal infection during the first trimester and

was characterized by chorioretinitis, hydrocephalus, and intracerebral calcifications. Congenital

rubella syndrome presented with cardiac anomalies, cataracts, and hearing loss.

Diagnostic confirmation required PCR testing of blood, urine, or CSF, as well as serological

assays for pathogen-specific IgM antibodies. Treatment regimens included ganciclovir for CMV,

pyrimethamine-sulfadiazine for toxoplasmosis, and penicillin G for congenital syphilis.

Prevention strategies such as maternal screening and immunization were identified as the most

effective control measures.

Neonatal Conjunctivitis (Ophthalmia Neonatorum)

Neonatal conjunctivitis was commonly reported within the first 2 weeks of life, particularly in

infants born to mothers with untreated sexually transmitted infections. Neisseria gonorrhoeae and

Chlamydia trachomatis were the leading bacterial causes.

Symptoms typically included eyelid swelling, purulent discharge, and conjunctival redness. Left

untreated, gonococcal conjunctivitis could rapidly progress to corneal ulceration and blindness.

Diagnosis was confirmed through Gram stain and culture of conjunctival exudate.

Treatment consisted of intramuscular ceftriaxone for gonorrhea and oral erythromycin or

azithromycin for chlamydia. Universal prophylaxis with erythromycin ointment at birth had

significantly reduced incidence in countries where it was routinely practiced.

Omphalitis

Omphalitis, defined as infection of the umbilical stump, was primarily observed in regions where

home births and poor hygiene practices were prevalent. The infection was typically

polymicrobial, involving Staphylococcus aureus, Streptococcus pyogenes, and Gram-negative

bacilli such as Klebsiella.

Clinical signs included erythema, swelling, purulent discharge, and in severe cases, abdominal

wall cellulitis and systemic sepsis. The use of chlorhexidine for umbilical cord care in high-risk

settings was associated with a significant reduction in neonatal mortality.

Treatment required systemic antibiotics and surgical intervention in advanced cases involving

https://ijmri.de/index.php/jmsi

volume 4, issue 4, 2025

1288

necrotizing fasciitis.

Neonatal Tetanus

Though largely eliminated in high-income countries through maternal immunization and

improved delivery hygiene, neonatal tetanus remained a significant cause of neonatal mortality

in rural and underserved areas. The disease was caused by Clostridium tetani spores

contaminating the umbilical stump.

Affected neonates typically presented within the first 5–14 days of life with generalized stiffness,

trismus, opisthotonos, and an inability to feed. Mortality exceeded 70% in untreated cases.

Tetanus toxoid vaccination during pregnancy and sterile delivery practices were crucial for

prevention.

Discussion

The burden of infectious diseases in the neonatal period remains one of the most pressing

challenges in global health. Despite significant advancements in neonatal care and infectious

disease control, infections continue to account for a substantial proportion of neonatal mortality

and long-term morbidity, particularly in low- and middle-income countries (LMICs). The

findings from the present review emphasize the persistent prevalence and clinical impact of

conditions such as sepsis, pneumonia, meningitis, conjunctivitis, umbilical infections, and

congenital TORCH infections.

Neonatal sepsis continues to be the foremost cause of infection-related neonatal deaths. The

distinction between early-onset sepsis (EOS) and late-onset sepsis (LOS) is crucial, not only

because of the different etiological agents involved but also due to their distinct

pathophysiological pathways and clinical implications. While EOS is often attributed to maternal

transmission and is more amenable to prevention through perinatal screening (e.g., for Group B

Streptococcus), LOS is largely a reflection of the hospital environment, prolonged

instrumentation, and compromised host defenses. The emergence of multidrug-resistant

organisms in NICU settings presents an escalating concern. Resistance patterns, particularly in

Klebsiella, Pseudomonas, and Acinetobacter species, threaten the efficacy of first-line empirical

therapies, thus complicating clinical management and increasing dependence on broad-spectrum

or last-resort antimicrobials such as carbapenems and colistin.

Pneumonia in neonates frequently overlaps with systemic sepsis but is often underdiagnosed due

to its subtle clinical presentation and limited access to diagnostic imaging in resource-poor

settings. The high prevalence of pneumonia among neonates delivered in unsanitary conditions,

especially in home births, underscores the urgent need for improvements in maternal and

perinatal healthcare. The role of maternal colonization with organisms like Chlamydia

trachomatis and Ureaplasma urealyticum further illustrates the interconnected nature of maternal

and neonatal health, reinforcing the importance of antenatal screening and treatment.

Neonatal meningitis, although less frequent than sepsis and pneumonia, represents a particularly

severe complication due to its high case fatality rate and devastating neurological sequelae. The

diagnostic gold standard—lumbar puncture and CSF analysis—remains underutilized in many

settings due to limited expertise or infrastructure. Moreover, nonspecific clinical signs in

neonates delay diagnosis and treatment initiation. There is a pressing need to develop point-of-

care diagnostics that are rapid, sensitive, and feasible for use in under-resourced environments.

https://ijmri.de/index.php/jmsi

volume 4, issue 4, 2025

1289

The burden of congenital infections, particularly those within the TORCH complex, illustrates

the transplacental transmission of pathogens with teratogenic potential. Despite the declining

global incidence of congenital rubella and syphilis due to widespread immunization and

screening efforts, congenital CMV and toxoplasmosis remain prevalent. Notably, congenital

CMV is the leading non-genetic cause of sensorineural hearing loss in neonates. The absence of

a licensed CMV vaccine and the variability in antiviral treatment outcomes present a significant

gap in neonatal infectious disease prevention. Furthermore, the high rate of asymptomatic

infection at birth with delayed onset of clinical manifestations poses a diagnostic and

management challenge for pediatricians.

Umbilical infections such as omphalitis exemplify the broader issue of infection control in

newborn care. Studies have consistently shown that topical antiseptics like chlorhexidine can

dramatically reduce the risk of omphalitis and related sepsis, especially in rural birth settings.

Nonetheless, traditional practices, lack of caregiver education, and cultural resistance often

hinder the implementation of evidence-based cord care interventions.

Conjunctivitis in neonates, though relatively less fatal, can have serious consequences including

blindness when caused by Neisseria gonorrhoeae. The inclusion of ocular prophylaxis in

neonatal care protocols has proven effective in high-income countries, yet remains inconsistently

applied in LMICs. The vertical transmission of sexually transmitted pathogens again emphasizes

the critical role of antenatal screening, treatment, and perinatal care.

Neonatal tetanus, while now rare in high-income settings, remains a major preventable cause of

neonatal mortality in parts of sub-Saharan Africa and South Asia. Its continued presence is an

indicator of inequities in maternal immunization coverage and access to skilled birth attendants.

The high fatality rate, often exceeding 70% in untreated cases, highlights the importance of

comprehensive maternal health strategies, including vaccination and clean delivery practices.

Across all these conditions, the common thread is that most neonatal infections are preventable

through timely maternal screening, improved birth hygiene, and appropriate postnatal care.

However, structural challenges such as inadequate healthcare infrastructure, shortage of skilled

personnel, lack of diagnostic equipment, and limited access to antibiotics significantly hinder the

delivery of optimal neonatal care in many parts of the world. These barriers are further

exacerbated by social determinants of health such as poverty, maternal education, and

geographic inaccessibility to healthcare facilities.

The discussion also reveals the need for innovation in diagnostics, therapeutics, and delivery of

neonatal care. Rapid diagnostic tests (RDTs) tailored for neonatal infections, particularly for

sepsis and congenital infections, could dramatically improve early detection and reduce mortality.

Additionally, investment in maternal immunization (e.g., for GBS and RSV), the development of

neonatal-specific antibiotics, and context-appropriate infection prevention protocols will be

essential moving forward.

Finally, there is a strong imperative for data-driven public health interventions. The integration

of neonatal infection surveillance into national health information systems, coupled with global

partnerships such as WHO’s Every Newborn Action Plan, offers an avenue for coordinated,

large-scale improvements in newborn health outcomes. Long-term success in reducing neonatal

infectious mortality will require a multifaceted approach that bridges clinical, community, and

policy-level efforts.

Conclusion

https://ijmri.de/index.php/jmsi

volume 4, issue 4, 2025

1290

The neonatal period represents a uniquely vulnerable window in human development during

which infectious diseases pose an immediate and often life-threatening risk to survival and long-

term health. This comprehensive review underscores the fact that, despite notable advances in

medical science and perinatal care, neonatal infections remain a leading cause of morbidity and

mortality worldwide. Diseases such as neonatal sepsis, pneumonia, meningitis, congenital

TORCH infections, omphalitis, conjunctivitis, and neonatal tetanus not only continue to exact a

heavy toll in low-resource settings but also remain clinically significant even in high-income

environments due to the emergence of antibiotic resistance and increasing prematurity rates.

One of the most striking conclusions drawn from the synthesis of current evidence is the central

role of early recognition and intervention in improving neonatal outcomes. The non-specific

clinical presentation of most neonatal infections necessitates a high degree of clinical suspicion

and readiness to initiate empiric therapy. Diagnostic limitations, particularly in rural or under-

resourced facilities, further complicate early identification, often delaying life-saving treatment.

Therefore, strengthening laboratory infrastructure, expanding access to rapid diagnostic tools,

and promoting clinical training in neonatal infection recognition must become priorities in global

health policy.

Equally important is the realization that prevention strategies are both effective and underutilized.

Interventions such as maternal screening for GBS, administration of prophylactic intrapartum

antibiotics, tetanus toxoid vaccination during pregnancy, safe cord care practices, and neonatal

prophylaxis for ophthalmia neonatorum have demonstrably reduced infection rates and mortality

in regions where they are consistently applied. However, inequities in healthcare access, cultural

practices, and policy enforcement limit the widespread adoption of these interventions in many

parts of the world. Bridging this gap requires coordinated efforts from international organizations,

governments, healthcare providers, and local communities.

Furthermore, the review brings attention to the interconnectedness of maternal and neonatal

health. Many neonatal infections originate from vertical transmission of maternal infections that

could be identified and managed during routine antenatal care. Strengthening maternal health

systems—through improved antenatal surveillance, universal screening for sexually transmitted

infections, and promotion of facility-based deliveries—is indispensable in the broader context of

neonatal infection prevention.

From a research and innovation perspective, the continued evolution of neonatal care demands

the development of pathogen-specific vaccines, especially for cytomegalovirus, GBS, and RSV,

as well as the creation of neonate-safe antimicrobials. Equally critical is the advancement of

point-of-care diagnostic technologies that are affordable, accurate, and deployable in low-

resource settings. The integration of such innovations into routine care would not only improve

survival but also reduce the overuse of broad-spectrum antibiotics and the accompanying risk of

antimicrobial resistance.

Lastly, the effective reduction of neonatal infection-related deaths will not be achieved through

clinical interventions alone. Social determinants of health—such as maternal education,

sanitation, nutrition, and poverty—must be addressed simultaneously to ensure sustainable

improvement. National and global strategies, such as the WHO’s Every Newborn Action Plan,

offer structured frameworks for improving neonatal survival, but success will ultimately depend

on how well these strategies are adapted and implemented within local contexts.

In conclusion, combating neonatal infectious diseases requires a comprehensive, multi-layered

approach that includes clinical vigilance, preventive medicine, policy-level commitment, and

community engagement. With continued investment in maternal and neonatal health systems, the

https://ijmri.de/index.php/jmsi

volume 4, issue 4, 2025

1291

global burden of neonatal infections can be significantly reduced, paving the way toward

healthier beginnings for millions of newborns around the world.

Literature:

1.

Shane, A. L., Sánchez, P. J., & Stoll, B. J. (2017). Neonatal sepsis.

The Lancet

,

390(10104), 1770–1780. https://doi.org/10.1016/S0140-6736(17)31002-4

2.

Sobirjonovich, S. I. (2023). Systemic Organization of Professional Competence,

Creativity and Innovative Activity of A Future Kindergartener.

Journal of Pedagogical

Inventions and Practices

,

19

, 108-112.

3.

Simonsen, K. A., Anderson-Berry, A. L., Delair, S. F., & Davies, H. D. (2014). Early-

onset

neonatal

sepsis.

Clinical

Microbiology

Reviews

,

27(1),

21–47.

https://doi.org/10.1128/CMR.00031-13

4.

Abdurashidov, A., & Turdaliyeva, N. (2023). DEVELOPMENT OF MANUAL WORK

IN PRE-SCHOOL EDUCATION.

Science and innovation

,

2

(B2), 282-286.

5.

Lawn, J. E., Cousens, S., & Zupan, J. (2005). 4 million neonatal deaths: When? Where?

Why?

The Lancet

, 365(9462), 891–900. https://doi.org/10.1016/S0140-6736(05)71048-5

6.

Мухамедова, М. Г., Куртиева, Ш. А., & Назарова, Ж. А. (2020). СИНДРОМ

ФУНКЦИОНАЛЬНОЙ КАРДИОПАТИИ У СОВРЕМЕННЫХ ПОДРОСТКОВ. In

П84

Профилактическая медицина-2020: сборник научных трудов Все-российской научно-

практической конференции с международным участи-ем. 18–19 ноября 2020 года/под ред.

АВ Мельцера, ИШ Якубовой. Ч. 2.—СПб.: Изд-во СЗГМУ им. ИИ Мечникова, 2020.—304

с.

(p. 105).

7.

World Health Organization. (2023).

Newborns: improving survival and well-being

.

https://www.who.int/news-room/fact-sheets/detail/newborns-reducing-mortality

8.

qizi Turdaliyeva, N. A. (2024). MAKTABGACHA YOSHDAGI BOLALAR IJODIY

QOBILIYATLARNI

RIVOJLANTIRISHNING

NAZARIY

ASOSLARI.

GOLDEN

BRAIN

,

2

(7), 48-52.

9.

Юллиев, Н. Ж. (2022). Определение физической подготовленности спасателей в

условиях среднегорья. In

ТРУДЫ ХIII ЕВРАЗИЙСКОГО НАУЧНОГО ФОРУМА

(pp. 259-

262).

10.

Turdaliyeva, N. (2025). DIFFERENT TYPES OF MANUAL LABOR FOR CHILDREN

AND THEIR IMPACT ON CREATIVE DEVELOPMENT.

Journal of Multidisciplinary

Sciences and Innovations

,

1

(1), 563-568.

11.

Файзуллаев, Т., & Хужамбердиева, Ш. (2020). ЭРКИН ВОҲИДОВ ИЖОДИНИ

УМУМИЙ

ЎРТА

ТАЪЛИМ

МАКТАБЛАРИДА

ЎРГАНИШДА

ЁШЛАРНИ

ВАТАПАРВАРЛИК РУҲИДА ТАРБИЯЛАШНИНГ АҲАМИЯТИ.

Scientific Bulletin of

Namangan State University

,

2

(4), 543-546.

12.

Boymirzayeva, S. (2025). DIDACTIC FORMS AND METHODS OF PEDAGOGICAL

SUPPORT AND TARGETED DEVELOPMENT OF CHILDREN IN THE PROCESS OF

PRESCHOOL EDUCATION.

Journal of Multidisciplinary Sciences and Innovations

,

1

(1), 557-

562.

13.

Turdaliyeva, N., & Mamadjonova, D. (2024). MAKTABGACHA TA’LIM

TASHKILOTLARIDA

BOLALARGA

TA’LIM-TARBIYA

BERISHDA

IJODIY

O’YINLARDAN FOYDALANISH.

Nordic_Press

,

5

(0005).

14.

Mukhamedova, M., & Arnopolskaya, D. (2013). The Nitric Oxide System in Patients

with Chronic Heart Failure.

International Journal of Biomedicine

,

3

(3), 180-183.

15.

Юллиев, Н. Ж., Сафарова, Д. Д., Мусаева, У. А., & Нурбаев, Б. Ш. (2015).

Особенности

физической

подготовки

спасателей

МЧС

с

учетом

условий

среднегорья.

Наука и спорт: современные тенденции

,

8

(3), 47-53.

https://ijmri.de/index.php/jmsi

volume 4, issue 4, 2025

1292

16.

Khujamberdieva, S. (2023). SPECIFIC TASKS OF INTRODUCING CHILDREN TO

LITERARY WORKS.

Collection of scientific papers «SCIENTIA»

, (May 5, 2023; Sydney,

Australia), 145-147.